Lv4
475 积分 2021-06-21 加入
VP279 Vaccination in patients with myasthenia gravis: coverage and safety
9天前
已完结
Biological therapies for myasthenia gravis
10天前
已完结
Targeted Treatments for Myasthenia Gravis in Children and Adolescents
10天前
已完结
Anti-CFH-associated hemolytic uremic syndrome: do we still need plasma exchange?
11天前
已完结
Therapeutic challenges and unmet needs in the management of myasthenia gravis: an Italian expert opinion
18天前
已完结
Eculizumab in refractory myasthenia gravis: a real-world single-center experience
18天前
已完结
Minimal symptom expression achievement over time in generalized myasthenia gravis
19天前
已完结
Myasthenic crisis in thymoma-associated myasthenia gravis: a multicenter retrospective cohort study
1个月前
已完结
Eculizumab in refractory myasthenic crisis
1个月前
已完结
皖公网安备34019202002308
